Flavonoids as functional food-derived modulators of the gut microbiota-NF-κB axis in metabolic dysfunction-associated steatotic liver disease
- 21 May 2026
- journal article
- review article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 481 (6) , 2357-2379
Abstract
Metabolically Dysfunctional-Associated Steatotic Liver Disease (MASLD) is increasingly recognised as a gut-liver axis disorder driven by sustained activation of pro-inflammatory signalling networks, particularly the NF-κB pathway. Flavonoids, a diverse class of dietary polyphenols, have emerged as promising modulators of NF-κB-mediated gut-liver crosstalk due to their capacity to restore intestinal homeostasis and suppress hepatic inflammation. This review synthesises recent preclinical evidence identifying NF-κB as a central mechanistic target underlying flavonoid actions in MASLD. A structured literature search was conducted in PubMed, Scopus, Web of Science, and ScienceDirect to identify studies published between 2020 and February 2026. Accumulating evidence indicates that flavonoids remodel the gut microbiota toward beneficial taxa. Several flavonoids also modulate upstream regulators, thereby converging on NF-κB to mitigate MASLD. To improve translational interpretation, animal experimental doses were contextualised using established human-equivalent dose conversion methods, alongside reported dietary sources and estimated achievable intake levels. Although the present work highlights the considerable potential of flavonoids as functional food-derived modulators of the gut microbiota NF-κB axis in MASLD, their clinical translation remains constrained by limited bioavailability and heterogeneity across experimental models, highlighting the need for standardised dosing strategies, integrated host microbiota analyses, and well-designed human studies to substantiate clinical applicability.Keywords
This publication has 113 references indexed in Scilit:
- Management of paediatric ulcerative colitis, part 1: Ambulatory care—An updated evidence‐based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis OrganisationJournal of Pediatric Gastroenterology and Nutrition, 2025
- Advanced extraction and encapsulation strategies for the use of red pitanga residues: improving polyphenol recovery and cell viability in a probiotic productJournal of Food Measurement and Characterization, 2025
- Study on the Mechanism of Fisetin Exerting Anti‐Liver Cancer Effects by Regulating Neutrophil Extracellular TrapsFood Science & Nutrition, 2025
- Flavonoid Polyphenols as Therapeutic Agents for Fatty Liver Disease: Mechanisms, Microbiome Interactions, and Metabolic InsightsMolecular Nutrition & Food Research, 2025
- Harvest Time Influences Quality and Storability of ‘Chandler’ Strawberries Grown Under Subtropical Conditions of PakistanApplied Fruit Science, 2025
- Hawthorn total flavonoids ameliorate hyperlipidemia through AMPK/SREBP1‐c and PPARα/PGC‐1α/CPT‐1A pathway activation and gut microbiota modulationJournal of the Science of Food and Agriculture, 2025
- Isoxanthohumol improves hepatic lipid metabolism via regulating the AMPK / PPARα and PI3K / AKT signaling pathways in hyperlipidemic miceFood Science & Nutrition, 2024
- Fibroblast growth factor 21 is a hepatokine involved in MASLD progressionUnited European Gastroenterology Journal, 2024
- Ligustrum robustum Alleviates Atherosclerosis by Decreasing Serum TMAO, Modulating Gut Microbiota, and Decreasing Bile Acid and Cholesterol Absorption in MiceMolecular Nutrition & Food Research, 2021
- Dietary flavonoid fisetin for cancer prevention and treatmentMolecular Nutrition & Food Research, 2016